[1]雷建平.耐多药结核病治疗研究现状及警示. 中华临床医师杂志(电子版),2009,3(8):1334-1341.[2]雷建平.重新审视结核病免疫治疗研究的方向和方法. 中华临床医师杂志(电子版),2010, 4(7):908-915.[3]Onyebujoh P,Rook GA. Tuberculosis. Nat Rev Microbiol,2004,2(12):930-932.[4]Fine PE. Variation in protection by BCG: implications of and for heterologous immunity. Lancet,1995,346(8986):1339-1345.[5]雷建平,彭燕,熊国亮,等.不同时期卡介苗免疫治疗对结核病大鼠疗效和 CD4+ CD8+ 双阳(DP)T细胞的影响.中国防痨杂志,2006,28(6):404-407.[6]雷建平,李剑,邓国防,等.结核病小鼠T淋巴细胞亚群及其表达的四项细胞因子分析.中华结核和呼吸杂志,2008,31(11):836-840.[7]石海燕,孙光. 结核病患者淋巴细胞亚群检测的临床意义.中国误诊学杂志,2006,6(7):1262-1263.[8]林艳荣,许丁空. 肺结核患者 T淋巴细胞亚群的检测及临床意义.内科,2007,2(3):320-321.[9]雷建平,王继香,章润泉,等.肺结核病人T细胞亚群和PPD抗体分析. 中华结核和呼吸杂志,1992,15(2):75-76.[10]雷建平,王继香,傅颖媛,等.卡介苗免疫治疗对结核病人临床疗效和T淋巴细胞亚群的影响. 实用临床医学,2002,3(1):1-5.[11]雷建平,王继香,周建年,等. 活卡介苗免疫治疗可缩短初治肺结核化疗疗程.中国免疫学杂志,1995,11(2):126.[12]雷建平,彭燕,熊国亮,等. 卡介苗接种对大鼠外周血中 CD4+ CD8+ 双阳 T淋巴细胞的影响.中华结核和呼吸杂志,2004,27(12):865-866.[13]雷建平,万引,周军,等. 卡介苗免疫小鼠T淋巴细胞亚群表达穿孔素与抗结核作用的相关性. 中华结核和呼吸杂志,2010,33(10): 771-774.[14]Klucar P, Barnes PF, Kong Y, et al. Characterization of effector functions of human peptide-specific CD4+ T cell clones for an intracellular pathogen. Hum Immunol, 2008,69(8): 475-483.[15]雷建平. CD4+CD8+双阳T细胞与结核病及卡介苗治疗相关性研究.中国科技成果,2009,10(6):58.[16]雷建平,熊国亮,胡群芳,等. 化疗加用卡介苗免疫治疗预防耐多药结核病的研究. 中华预防医学杂志,2008,42(2):86-89.[17]张慧洁,陈兰举,陈名武. T淋巴细胞亚群在结核感染免疫反应中的作用.实用儿科临床杂志,2006,21(19):1342-1343.[18]Andersen P,Doherty TM. The success and failure of BCG-implications for a novel tuberculosis vaccine.Nat Rve Microbiol,2005,3(8):656-662.[19]Behr MA,Wilson MA,Gill WP,et al.Comparative genomics of BCG vaccines by whole-genome DNA microarray.Science,1999,284(5419):1520-1523.[20]孙颖,张灵霞,吴雪琼,等.mpt64-卡介苗重组疫苗的构建、免疫原性及抗结核作用. 中国生物工程杂志,2011,37(7):14-19.[21]Delogu G, Fadda G.The quest for a new vaccine against tuberculosis.J Infect Dev Ctries, 2009,3(1):5-15.[22]Sarhan MA. Tuberculosis vaccine. Saudi Med J, 2010,31(1):9-13.[23]Jeyanathan M, Mu J, Kugathasan K, et al. Airway delivery of soluble mycobacterial antigens restores protective mucosal immunity by single intramuscular plasmid DNA tuberculosis vaccination: role of proinflammatory signals in the lung. J Immunol, 2008,181(8): 5618-5626.[24]Santos RR Junior, Sartori A, Lima DS, et al. DNA vaccine containing the mycobacterial hsp65 gene prevented insulitis in MLD-STZ diabetes. J Immune Based Ther Vaccines, 2009,7(1):4.[25]Rodríguez D, Vizcaíno C, Ocampo M, et al. Peptides from the Mycobacterium tuberculosis Rv1980c protein involved in human cell infection: insights into new synthetic subunit vaccine candidates. Biol Chem, 2010,391(2/3):207-217.[26]Lowrie DB, Tascon RE, Bonato VL, et al. Therapy of tuberculosis in mice by DNA vaccination. Nature, 1999, 400(6741):269-271.[27]Zhu D, Jiang S, Luo X. Therapeutic effects of Ag85B and MPT64 DNA vaccines in a murine model of Mycobacterium tuberculosis infection. Vaccine, 2005, 23(37):4619-4624.[28]Silva CL, Bonato VL, Coelho-Castelo AA, et al. Immunotherapy with plasmid DNA encoding mycobacterial hsp65 in association with chemotherapy is a more rapid and efficient form of treatment for tuberculosis in mice. Gene Ther, 2005, 12(3):281-287.[29]Liang Y, Wu X, Zhang J, et al. The treatment of mice infected with multi-drug-resistant Mycobacterium tuberculosis using DNA vaccines or in combination with rifampin. Vaccine, 2008, 26(35):4536-4540. |